Figure 1.
Comparison of gut microbiota between patients with DLBCL and healthy controls. (A) Description of the study. (B-C) Comparisons of alpha diversity using the Shannon index, and beta diversity using the Bray-Curtis index between patients with DLBCL and healthy controls. (D-E) Comparisons of the relative abundance at the phylum level between patients with DLBCL and healthy controls. (F-G) Comparisons of the relative abundance at the family level between patients with DLBCL and healthy controls. Asterisks indicate significant differences identified using the 2-tailed Mann-Whitney U test; ∗P < .05; ∗∗P < .01; ∗∗∗P < .001. HC, healthy controls; ns, not significant.

Comparison of gut microbiota between patients with DLBCL and healthy controls. (A) Description of the study. (B-C) Comparisons of alpha diversity using the Shannon index, and beta diversity using the Bray-Curtis index between patients with DLBCL and healthy controls. (D-E) Comparisons of the relative abundance at the phylum level between patients with DLBCL and healthy controls. (F-G) Comparisons of the relative abundance at the family level between patients with DLBCL and healthy controls. Asterisks indicate significant differences identified using the 2-tailed Mann-Whitney U test; ∗P < .05; ∗∗P < .01; ∗∗∗P < .001. HC, healthy controls; ns, not significant.

Close Modal

or Create an Account

Close Modal
Close Modal